COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL studyThomas Chatzikonstantinou, Elżbieta Kalicińska, Dominique Bron et al.|Leukemia|2021Cited by 94
The evolving landscape of <scp>COVID</scp>‐19 and <scp>post‐COVID</scp> condition in patients with chronic lymphocytic leukemia: A study by <scp>ERIC</scp>, the <scp>European</scp> research initiative on <scp>CLL</scp>Andrea Visentin, Gilad Itchaki, Thomas Chatzikonstantinou et al.|American Journal of Hematology|2023Cited by 21
Accuracy and prognostic impact of <scp>FDG PET</scp>/<scp>CT</scp> and biopsy in bone marrow assessment of follicular lymphoma at diagnosis: A <scp>Nation‐Wide</scp> cohort studyIsabel Ródenas‐Quiñonero, Francisco José Ortuño, Tzu Hua Chen‐Liang et al.|Cancer Medicine|2022Cited by 8
THE ROLE OF FDG‐PET/CT AND BONE MARROW BIOPSY IN DETECTING BONE MARROW INVOLVEMENT IN THE INITIAL STAGING OF FOLLICULAR LYMPHOMA: AN ANALYSIS OF ACCURACY AND PROGNOSTIC IMPACTL. Reguilón Gallego, Francisco José Ortuño, Taoyun Liang et al.|Hematological Oncology|2021Cited by 0
Differences in Clinical Course and Management of Sars-CoV2 Infection in Patients with Chronic Lymphocytic Leukemia between the Sequential Pandemic Phases: An Eric StudyAndrea Visentin, Mark‐David Levin, Lydia Scarfò et al.|Blood|2022Cited by 0